Your browser doesn't support javascript.
loading
Eomes Impedes Durable Response to Tumor Immunotherapy by Inhibiting Stemness, Tissue Residency, and Promoting the Dysfunctional State of Intratumoral CD8+ T Cells.
Sun, Runzi; Wu, Yixian; Zhou, Huijun; Wu, Yanshi; Yang, Zhongzhou; Gu, Yanzheng; Jiang, Jingting; Lu, Binfeng; Zhu, Yibei.
Afiliación
  • Sun R; Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, Changzhou, China.
  • Wu Y; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
  • Zhou H; Department of Immunology, School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China.
  • Wu Y; Department of Immunology, School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China.
  • Yang Z; Department of Immunology, School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China.
  • Gu Y; Model Animal Research Center of Nanjing University, Nanjing, China.
  • Jiang J; Jiangsu Key Laboratory of Clinical Immunology, Soochow University, Suzhou, China.
  • Lu B; Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, Changzhou, China.
  • Zhu Y; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Front Cell Dev Biol ; 9: 640224, 2021.
Article en En | MEDLINE | ID: mdl-33553191

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Cell Dev Biol Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Cell Dev Biol Año: 2021 Tipo del documento: Article País de afiliación: China